Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin
Johannes Hoffmann, Steven M. Opal(Brown University), Josef Briegel(LMU Klinikum), Mathias Juers, Christian J. Wiedermann(Eurac Research), Helmut Ostermann(LMU Klinikum), Joachim Kienast(University of Münster), Richard Strauß(Hennepin County Medical Center), Brian Warren(Stellenbosch University)
Cited by 85
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k